Stay updated on IPI-145 Plus FCR in CLL Clinical Trial
Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedUpdates shown (2026-01, 2026-01-27, 2026-02-13) appear to be administrative metadata changes to the study record, such as new update timestamps, and do not modify core content like eligibility criteria, endpoints, or interventions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with deletion of the funding-status notice, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide Notice about government funding and NIH Clinical Center operations was added, and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page adds a glossary display and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) with a new Revision: v3.4.0, replacing older metadata items (Last Update Posted (Estimated), No FEAR Act Data, Revision: v3.3.4).SummaryDifference0.3%

- Check56 days agoChange DetectedThe page deleted the Study Protocol and Statistical Analysis Plan PDF, the Study Documents section, investigators and institution names, IPD sharing details, and related drug and MeSH term metadata.SummaryDifference19%

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.